| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 95,323 | 84,940 | ||
| Marketable securities | 176,402 | 209,788 | ||
| Interest receivable | 1,237 | 1,775 | ||
| Prepaid assets | 3,516 | 2,300 | ||
| Prepaid clinical | 4,351 | 5,723 | ||
| Assets held for sale | 19,050 | 19,368 | ||
| Other current assets | 110 | 546 | ||
| Total current assets | 299,989 | 324,440 | ||
| Fixed assets, net | 47,754 | 43,525 | ||
| Right of use assets, net | 3,865 | 4,168 | ||
| Total assets | 351,608 | 372,133 | ||
| Accounts payable | 1,942 | 2,443 | ||
| Lease liabilities | 991 | 903 | ||
| Accrued expenses and other | 26,068 | 24,916 | ||
| Income taxes payable | 62 | 0 | ||
| Total current liabilities | 29,063 | 28,262 | ||
| Income tax payable, net of current portion | 962 | 903 | ||
| Lease liabilities, net of current portion | 3,245 | 3,515 | ||
| Total liabilities | 33,270 | 32,680 | ||
| Redeemable noncontrolling interest | 1,326,358 | 1,341,953 | ||
| Common stock value-Common Class A | 14 | 13 | ||
| Common stock value-Common Class B | 16 | 16 | ||
| Additionalpaid-incapital | 242,480 | 231,576 | ||
| Accumulated other comprehensive gain | 74 | 30 | ||
| Accumulated deficit | -1,250,604 | -1,234,135 | ||
| Total shareholders' deficit | -1,008,020 | -1,002,500 | ||
| Total liabilities and shareholders' deficit | 351,608 | 372,133 | ||
PROKIDNEY CORP. (PROK)
PROKIDNEY CORP. (PROK)